Oct 20 (Reuters) - Kenvue (KVUE.N), opens new tab has urged U.S. regulators to reject a request seeking autism warning label on its popular over-the-counter pain medication Tylenol for use during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback